SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 598.89 |
Enterprise Value ($M) | 575.40 |
Book Value ($M) | 109.46 |
Book Value / Share | 3.81 |
Price / Book | 5.47 |
NCAV ($M) | 106.27 |
NCAV / Share | 3.70 |
Price / NCAV | 5.64 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.69 |
Return on Assets (ROA) | -0.61 |
Return on Equity (ROE) | -0.67 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 7.04 |
Current Ratio | 7.04 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 124.23 |
Assets | 127.42 |
Liabilities | 17.96 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -81.41 |
Net Income | -75.52 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -56.78 |
Cash from Investing | 11.88 |
Cash from Financing | 46.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Ra Capital Management, L.p. | 28.90 | 0.25 | |
13D/A | Sofinnova Venture Partners X, L.P. | 13.80 | 0.63 | |
13G/A | Cormorant Asset Management, LP | 4.38 | -38.09 | |
13G/A | Baker Bros. Advisors Lp | 6.10 | -14.99 | |
13G/A | Citadel Advisors Llc | 0.00 | ||
13G | TCG Crossover GP I, LLC | 8.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
29,764 | 109,092 | 27.28 | |
29,797 | 139,933 | 21.29 | |
24,826 | 31,398 | 79.07 | |
19,340 | 19,018 | 101.69 | |
(click for more detail) |
Similar Companies | |
---|---|
AURA – Aura Biosciences, Inc. | AVBP – ArriVent BioPharma, Inc. |
AVDL – Avadel Pharmaceuticals plc | AXSM – Axsome Therapeutics, Inc. |
BCAB – BioAtla, Inc. |
Financial data and stock pages provided by
Fintel.io